| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/20/1991 | CN1049353A Cyclic neurokinin a antagonists |
| 02/20/1991 | CN1049349A 2-oxo-1-oxa-8-azaspiro (4,5) decane derivatives, pharmaceutical compositions containing them and process for preparing same |
| 02/20/1991 | CN1049348A 2-oxa-1-oxo-8-azaspiro (4,5) decane derivatives, pharmaceutical compositions containing them and process for preparing same |
| 02/20/1991 | CN1049347A 2-oxa-1-oxo-8-azaspiro ¾4,5 decane derivatives, pharmaceutical compositions containing them and process for preparing same |
| 02/20/1991 | CN1049342A Process for preparation of benzopyran having pharmacological activity |
| 02/19/1991 | US4994617 Aminoalcohols, their preparation process and their applications, particularly in therapeutics |
| 02/19/1991 | US4994612 Ylidene sulfonamide derivatives |
| 02/19/1991 | US4994569 5,6-dihydro-4H-1,3-oxa(or thia)zine derivatives, their preparation and compositions containing them |
| 02/19/1991 | US4994483 5-substituted-3-aminoalkyl indole derivatives for migraine |
| 02/19/1991 | US4994475 Method for potentiating an immune response with derivatives |
| 02/19/1991 | US4994474 Hypotensive agents |
| 02/19/1991 | US4994472 1-(pyridinylamino)-2-pyrrolidinones as pain relievers |
| 02/19/1991 | US4994460 Treatment or prevention of disorders resulting from central nervous system anoxia |
| 02/19/1991 | US4994455 Anti-anxiety agents |
| 02/19/1991 | US4994452 Hexahydro-1H-quino[4,3,2-ef][1,4]benzoxazepines and related compounds |
| 02/19/1991 | US4994450 Azacyclic compounds and their use as analgesic agents |
| 02/19/1991 | US4994448 Condensed quinolinium and isoquinolinium derivatives |
| 02/19/1991 | CA1280421C 1,4-disubstituted piperidinyl derivatives |
| 02/18/1991 | CA2023349A1 Agents for the treatment of conditions of heavy pain and processes for preparing said agents |
| 02/17/1991 | CA2023233A1 Halogenoalkylphenyl-alcohols, ketones and hydrates thereof |
| 02/15/1991 | WO1991003226A2 Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same |
| 02/15/1991 | CA2064575A1 Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same |
| 02/13/1991 | EP0412941A2 Phospholipids for the treatment of multiple sclerosis |
| 02/13/1991 | EP0412899A2 Oxazolo pyridine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/13/1991 | EP0412898A1 Oxazolo-pyridine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/13/1991 | EP0412822A2 4,4-Disubstituted piperidine derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 02/13/1991 | EP0412821A2 1-oxa-2-oxo-3,8-diazaspiro[4,5]decane derivatives, pharmaceutical compositions containing them and processes for preparing them |
| 02/13/1991 | EP0412820A2 2-Oxo-1-oxa-8-azaspiro[4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 02/13/1991 | EP0412798A2 Substituted pyridines, their preparation, formulations and use in dementia |
| 02/13/1991 | EP0412797A2 The therapeutic use of substituted benzenes, formulations thereof and novel substituted benzenes |
| 02/13/1991 | EP0412760A2 Benzopyran derivatives |
| 02/13/1991 | EP0412643A1 Flow control system for ink cartridges |
| 02/13/1991 | EP0412542A2 Cyclic neurokinin antagonists |
| 02/13/1991 | EP0412470A2 Benzo[b]pyrrolo[3,2,1-jk]benzodiazepines, a process and intermediates for their preparation and their use as medicaments |
| 02/13/1991 | CN1049165A N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe and phenethylamine derivatives |
| 02/13/1991 | CN1049162A Dopamine agonists |
| 02/13/1991 | CN1049159A Heterocyclic compounds containing nitrogen and sulfur, pharmaceutical composition containing same and process for preparing them |
| 02/13/1991 | CN1049156A Indenoindole compounds i |
| 02/13/1991 | CN1049120A Process for producing synthetic materials |
| 02/12/1991 | WO1991001973A1 Kynurenic acid derivatives, their preparation and pharmaceutical compositions containing them |
| 02/12/1991 | WO1991001739A1 Dopaminergic neurotrophic factor for treatment of parkinson's disease |
| 02/12/1991 | US4992474 Phenethanolamine derivatives |
| 02/12/1991 | US4992441 Psychotherapy |
| 02/12/1991 | US4992436 Spiro-azabicyclic muscarinic agonists |
| 02/12/1991 | CA2064787A1 Dopaminergic neurotrophic factor for treatment of parkinson's disease |
| 02/12/1991 | CA2064566A1 Kynurenic acid derivatives, their preparation and pharmaceutical compositions containing them |
| 02/12/1991 | CA2021880A1 Psycho-pharmacological peptides |
| 02/12/1991 | CA1280115C Benzo b thiophen and benzo b furancarboxamides, their preparation and medicaments comprising the same |
| 02/11/1991 | CA2023015A1 4-methylene-2-oxo-8-azaspiro /4,5/decane derivatives, pharmaceutical compositions containing them and process for preparing the same |
| 02/09/1991 | WO1991001729A1 Partial agonists of the strychnine insensitive glycine modulatory site of the n-methyl-d-aspartate receptor complex as neuropsychopharmacological agents |
| 02/09/1991 | CA2022886A1 Substituted pyridines, their preparation, formulations and use in dementia |
| 02/09/1991 | CA2022885A1 Substituted pyrazine, formulations thereof and use in medicine |
| 02/08/1991 | CA2022732A1 Oxazolo pyridine derivatives, process for their preparation and pharmaceutical compositions containing the same |
| 02/07/1991 | WO1991001133A1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 02/07/1991 | WO1990015069A3 Amino acid derivative anticonvulsant |
| 02/06/1991 | EP0412058A1 1-acyl-2-pyrrolidinones as enhancers of learning and memory and pharmaceutical compositions containing same |
| 02/06/1991 | EP0412014A1 Benzothiazine derivatives, their preparation and their uses as medicines or as intermediates for the synthesis of medicines |
| 02/06/1991 | EP0411775A1 Heterocyclic compounds containing nitrogen and sulfur, processes for their preparation and pharmaceutical compositions thereof |
| 02/06/1991 | EP0411736A1 11-Beta substituted 16-alpha, 17-alpha-methylene-estra-4,9-dien-3-one |
| 02/06/1991 | EP0411734A1 11-Beta-Aryl-16,16-alpha-cyclohexano-estra-4,9-diene progesterone inhibitors |
| 02/06/1991 | EP0411733A2 11-Beta-aryle-gona-4,9-dien-3-ones |
| 02/06/1991 | EP0411702A1 4-(2-methyl-2-hydroxypropyl-amino)-5,6-dihydrothieno-2(2,3-B)thiopyran-2-sulfonamide-7,7-dioxide |
| 02/06/1991 | EP0411668A2 Central cholecystokinin antagonists for treatment of psychiatric disorders |
| 02/06/1991 | EP0411631A1 Anti-psychotic compounds |
| 02/06/1991 | EP0411619A1 Formulations of phenytoin sodium for intravenous administration |
| 02/06/1991 | EP0411616A1 4-(N-substituted amino)-2-butynyl-1-carbamates and thiocarbamates and derivatives thereof as centrally acting muscarinic agents |
| 02/06/1991 | EP0411615A1 4-(N-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents |
| 02/06/1991 | EP0411534A2 Derivatives of 1,2,3,4-tetrahydro-9-acridinamine |
| 02/06/1991 | CA2022633A1 Compounds |
| 02/05/1991 | US4990614 Glutamate receptor inhibitors |
| 02/05/1991 | US4990535 Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine |
| 02/05/1991 | US4990534 Aralkyl esters and processes for their preparation |
| 02/05/1991 | US4990531 Derivatives of 1-arylsulphonyl-2-pyrrolidinone and their use as medicaments |
| 02/05/1991 | US4990516 Ameliorating agent for dysmnesia |
| 02/05/1991 | CA2022462A1 Aminoketone derivatives and use thereof |
| 02/05/1991 | CA2022460A1 Benzothiazimig derivatives, their preparation and applications as medicaments or as intermediates in the systhesis of medicaments |
| 02/05/1991 | CA1279824C Pharmaceutical and dietary composition containing -linolenic acid |
| 02/05/1991 | CA1279823C Pharmaceutical and dietary composition for pre-menstrual syndrome |
| 02/04/1991 | WO1991001732A1 Slowly dissociating (tight binding) dopamine, serotonin or norepinephrine reuptake inhibitors as cocaine, amphetamine and phencyclidine antagonists |
| 02/04/1991 | CA2064574A1 Slowly dissociating (tight binding) dopamine, serotonin or norepinephrine reuptake inhibitors as cocaine, amphetamine and phencyclidine antagonists |
| 02/03/1991 | CA2022513A1 Formulations of phenytoin sodium for intravenous administration |
| 02/03/1991 | CA2022511A1 4-(n-substituted amino)-2-butynyl-1-carbamates and thiocarbamates and derivatives thereof as centrally acting muscarinic agents |
| 02/03/1991 | CA2022510A1 4-(n-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents |
| 02/01/1991 | WO1991001725A1 A NOVEL USE OF β-RECEPTOR BLOCKING AGENTS FOR TREATMENT OF MENIERES' DISEASE |
| 02/01/1991 | CA2022118A1 4-(2-methyl-2-hydroxypropylamino)-5,6-dihydrothieno-[2,3-b] thiopyran-2-sulfonamide-7,7-dioxide |
| 01/30/1991 | EP0410883A2 Di-lysogangliosides derivatives |
| 01/30/1991 | EP0410881A2 Semisynthetic ganglioside analogues |
| 01/30/1991 | EP0410641A2 Dopamine agonists |
| 01/30/1991 | EP0410535A2 Octahydrobenzisoquinoline derivatives as antipsychotic agents |
| 01/30/1991 | EP0410509A1 New substituted 1H-indazole-3-carboxamides |
| 01/30/1991 | EP0410389A1 Indolocarbazol and its use |
| 01/30/1991 | EP0410208A1 Chroman derivatives |
| 01/30/1991 | EP0410114A2 Use of 4-[4-(5-fluoro-2-pyrimidinyl)-1-piperazinyl]-1-(4-fluorophenyl)-butanol in pharmaceutical compositions for the treatment of ischemia in brain |
| 01/30/1991 | EP0395683A4 Nicotine compositions |
| 01/30/1991 | EP0236390B1 Agent against multiple sclerosis |
| 01/29/1991 | US4988809 2-pyrimidinyl-1-piperazine derivatives, processes for their preparation and medicaments containing them |
| 01/29/1991 | US4988733 N-[1-(3-phenoxyphenyl)ethyl]acetohydroxamic acid compounds which are useful anti-inflammatory agents |
| 01/29/1991 | US4988717 Cardiovascular disorders, circulation |
| 01/29/1991 | US4988706 Certain pharmaceutically useful oxadiazoles |
| 01/29/1991 | US4988692 Cholecystokinine antagonist as analgesics, hyperglycemics, gastrointestinal disorders |